Who Owns Morgan Stanley? Top Shareholders and Recent Insider Trades

Nikko Henson6 minute read
Reviewed by: Thomas Richmond
Last updated Sep 4, 2025

@suphakit73 from Getty Images via Canva

Unlock our Free Report: 5 undervalued compounders with upside based on Wall Street’s growth estimates that could deliver market-beating returns (Sign up for TIKR, it’s free) >>>

Morgan Stanley (NYSE: MS) is a global financial services firm that provides investment banking, trading, wealth management, and asset management to clients worldwide. The company is one of the most influential institutions on Wall Street, recently trading around $149 per share with a market cap near $240 billion. Over the last year, shares have climbed about 47%, reflecting both strong operating momentum and renewed investor confidence in its diversified model.

For investors, Morgan Stanley represents a blend of traditional Wall Street deal-making strength and the steady growth of fee-based wealth management. Its scale in advisory services, trading, and asset management gives it a competitive position that few rivals can match.

Looking at the shareholder breakdown gives a clearer picture of how big investors and insiders may be thinking about Morgan Stanley today.

Who Are Morgan Stanley’s Top Shareholders?

Morgan Stanley stock
Morgan Stanley’s largest shareholders

See whether Morgan Stanley’s top shareholders are buying or selling today >>>

Morgan Stanley provides investment banking, trading, wealth management, and asset management services to clients around the world. Its shareholder base is dominated by large institutions, with passive index funds holding some of the biggest stakes.

  • Mitsubishi UFJ Financial Group: 377.1M shares (23.6%), ~$56.7B. No change.
  • The Vanguard Group: 118.6M shares (7.4%), ~$17.8B. Added 1.34M shares (+1.1%).
  • State Street Global Advisors: 104.1M shares (6.5%), ~$15.7B. Cut 3.0M shares (-2.8%).
  • BlackRock: 60.8M shares (3.8%), ~$9.2B. Trimmed 1.8M shares (-2.9%).
  • Capital International Investors: 27.2M shares (1.7%), ~$4.1B. Small increase (+0.6%).
  • Geode Capital: 26.6M shares (1.7%), ~$4.0B. Slight trim (-0.1%).
  • Fisher Investments: 24.0M shares (1.5%), ~$3.6B. Added 749K shares (+3.2%).
  • JP Morgan Asset Management: 21.9M shares (1.4%), ~$3.3B. Boosted 1.1M shares (+5.2%).

One highlight from last quarter is Balyasny Asset Management, run by Dmitry Balyasny, which lifted its Morgan Stanley stake by an eye-popping 1,430% to 1.23M shares worth about $173 million. That kind of sharp increase looks like a big swing in confidence toward the stock.

Another notable move came from Squarepoint Ops, which boosted its position by 750% to 1.68M shares valued at $237 million. This jump suggests the quant-driven firm sees Morgan Stanley as an attractive opportunity.

Schonfeld Strategic Advisors, led by Steven Schonfeld, raised its stake by nearly 198% to around 395K shares worth $56 million. The scale-up may point to growing conviction in the company’s stability and earnings outlook.

Finally, Citadel Advisors, managed by Ken Griffin, more than doubled its position, adding 2.1M shares for a total of 3.85M worth about $543 million. For one of the world’s largest hedge funds, this expansion could signal confidence in Morgan Stanley’s role as a core financial stock.

Mitsubishi UFJ’s massive stake gives Morgan Stanley a stable long-term anchor. Vanguard’s increase and Fisher’s additions may point to confidence in the firm’s earnings power, while trimming by BlackRock and State Street suggests some caution. Overall, institutions treat Morgan Stanley as a core financial holding, but appetite for adding more at current prices looks mixed.

Track the top shareholders of over 50,000 global stocks (It’s free) >>>

Morgan Stanley’s Recent Insider Trades

Morgan Stanley stock
Morgan Stanley’s recent insider transactions

Insider trading can provide a window into how executives and directors view their company’s stock. While motivations vary, clusters of sales or rare purchases can give hints about sentiment.

For Morgan Stanley, recent filings show a clear tilt toward selling as the stock climbed, with only one modest purchase breaking the pattern.

Here are some recent insider sales:

  • Michael Pizzi (Officer): Sold 18K shares at ~$141.
  • Eric Grossman (Officer): Sold 12K shares at ~$141.
  • Andrew Saperstein (Officer): Sold 43.6K shares at ~$141.
  • Daniel Simkowitz (Officer): Sold 36.6K shares at ~$141.
  • Sharon Yeshaya (Officer): Sold 25.6K shares at ~$140.
  • Charles Smith III (Officer): Sold 20K shares at ~$140.
  • Thomas Glocer (Director): Bought 843 shares in the open market at ~$128.

Insider trades appear mostly tilted toward selling, which may suggest leaders are comfortable reducing exposure after the stock’s rally. While these sales could reflect personal planning or diversification, the lack of meaningful buying adds a cautious undertone.

The small purchase by Director Thomas Glocer shows some willingness to add at lower levels.

See recent insider trade data for over 50,000 global stocks (It’s free) >>>

What the Ownership & Insider Trade Data Tell Us

Morgan Stanley’s shareholder base is anchored by passive giants like Mitsubishi UFJ, Vanguard, and State Street, which helps keep the stock firmly tied to global index flows. Among active managers, JP Morgan and Fisher have been adding, which may signal growing confidence in the firm’s earnings power. At the same time, reductions from BlackRock and State Street suggest a more cautious stance from other large holders.

Insider activity appears cautious as well, with several senior officers selling shares after the recent rally. The absence of meaningful insider buying may indicate that management is more comfortable trimming positions than adding at today’s valuation. Director Thomas Glocer’s modest purchase stands out, but its small size limits the overall signal.

The picture looks mixed. Institutions continue to treat Morgan Stanley as a core financial holding, but insider selling and selective fund moves suggest that conviction is measured. Investors may be supportive of the company’s long-term strength while showing less urgency to add aggressively at current prices.

Wall Street Analysts Are Bullish on These 5 Undervalued Compounders With Market-Beating Potential

TIKR just released a new free report on 5 compounders that appear undervalued, have beaten the market in the past, and could continue to outperform on a 1-5 year timeline based on analysts’ estimates.

Inside, you’ll get a breakdown of 5 high-quality businesses with:

  • Strong revenue growth and durable competitive advantages
  • Attractive valuations based on forward earnings and expected earnings growth
  • Long-term upside potential backed by analyst forecasts and TIKR’s valuation models

These are the kinds of stocks that can deliver massive long-term returns, especially if you catch them while they’re still trading at a discount.

Whether you’re a long-term investor or just looking for great businesses trading below fair value, this report will help you zero in on high-upside opportunities.

Click here to sign up for TIKR and get our full report on 5 undervalued compounders completely free.

Related Posts

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required